Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to $119.3 million.

  • Avidity Biosciences' Shares Outstanding (Weighted Average) rose 17.17% to $128.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.7 million, marking a year-over-year increase of 17.17%. This contributed to the annual value of $119.3 million for FY2024, which is 61.01% up from last year.
  • Avidity Biosciences' Shares Outstanding (Weighted Average) amounted to $119.3 million in FY2024, which was up 61.01% from $74.1 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Shares Outstanding (Weighted Average) registered a high of $119.3 million during FY2024, and its lowest value of $37.5 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $74.1 million (2023), whereas its average is $82.6 million.
  • Data for Avidity Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 61.01% (in 2024) over the last 5 years.
  • Avidity Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $37.5 million in 2020, then increased by 24.97% to $46.9 million in 2021, then increased by 16.13% to $54.5 million in 2022, then soared by 36.06% to $74.1 million in 2023, then surged by 61.01% to $119.3 million in 2024.